A Unified Agent-Enabled Platform for Drug Repurposing across Molecular, Phenotypic, and Clinical Scales

growth inhibition. These results establish LinkD as a scalable, multi-scale framework for systematic drug repurposing.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-04-22
DOI
https://doi.org/10.64898/2026.04.19.719462
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Unified Agent-Enabled Platform for Drug Repurposing across Molecular, Phenotypic, and Clinical Scales

Goutam Chakraborty, C Wang, Mohamed El Moussaoui, Nabila Zaman et al.
bioRxiv (Cold Spring Harbor Laboratory)
Bioinformatics and Genomic Networks
article

A Unified Agent-Enabled Platform for Drug Repurposing across Molecular, Phenotypic, and Clinical Scales

Goutam Chakraborty, C Wang, Mohamed El Moussaoui, Nabila Zaman, Serge Merzliakov, Kuan-lin Huang, Dongdong Zhang, Prathiksha Prabhakaraalva
article en

Abstract

growth inhibition. These results establish LinkD as a scalable, multi-scale framework for systematic drug repurposing.

bioRxiv (Cold Spring Harbor Laboratory)
Shandong University (CN), Tisch Hospital (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 15%
Bioinformatics and Genomic Networks
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.